Lupus
Cutaneous lupus diagnosed, treated and monitored.
Lupus can affect the skin alone or as part of systemic disease. Cutaneous forms include discoid lupus, subacute cutaneous lupus and the malar rash of systemic lupus erythematosus — all photosensitive, all requiring accurate diagnosis.
- Biopsy
- Diagnosis
- None
- Downtime
- 6–12 wks
- First results
- Long term
- Care

- Antimalarial therapy
- Potent topical & injected corticosteroids
- Systemic immunosuppression
- Skin biopsy & antibody panel
Diagnosed first, treated second.
Discoid lesions can scar and cause permanent hair loss, so early suppression of inflammation matters. Skin findings are also a window into systemic involvement, which is screened for at the outset.
- 01Antimalarial therapy
- 02Potent topical & injected corticosteroids
- 03Systemic immunosuppression
- 04Skin biopsy & antibody panel
- 05Rigorous photoprotection
- Persistent butterfly rash across the cheeks
- Scarring discoid patches on the scalp or face
- Rashes worsened by sunlight
- Known systemic lupus with skin involvement
- Unexplained photosensitive eruption
How the treatment works
A sequence, not a single appointment — each step informs the next.
- 01
Diagnosis
Clinical examination with skin biopsy and immunofluorescence where required.
- 02
Systemic screen
Autoantibody panel and organ review determine whether disease extends beyond the skin.
- 03
Suppression
Topical, injected and systemic anti-inflammatory therapy including antimalarials.
- 04
Long-term care
Photoprotection and structured review maintain remission and detect change early.

Results measured, not promised.
What to expect
- 01Active lesions settled
- 02Scarring and pigment loss limited
- 03Systemic involvement identified early
- 04Photosensitivity managed
- 05Coordinated care with rheumatology when needed
Begin with a diagnosis,
not a guess.
Share a few details and the clinic will reply with available consultation times for lupus — one-to-one with Dr. Arely.
- Response
- Within 24 hours
- Consultation
- One-to-one, 45 min
- Assessment
- Trichoscopy included
- Location
- Dr. Arely Clinic
Frequently asked
Not necessarily. Many patients have skin-limited disease, but screening is essential.
They can, which is why suppressing inflammation early is the priority.
Ultraviolet light triggers the immune reaction in the skin; daily protection is non-negotiable.
Often long term, though doses are reduced considerably once remission is stable.